Advertisement
Research Article Free access | 10.1172/JCI115721
Department of Laboratory Medicine, University of California, San Francisco 94143.
Find articles by Hung, D. in: JCI | PubMed | Google Scholar
Department of Laboratory Medicine, University of California, San Francisco 94143.
Find articles by Vu, T. in: JCI | PubMed | Google Scholar
Department of Laboratory Medicine, University of California, San Francisco 94143.
Find articles by Wheaton, V. in: JCI | PubMed | Google Scholar
Department of Laboratory Medicine, University of California, San Francisco 94143.
Find articles by Ishii, K. in: JCI | PubMed | Google Scholar
Department of Laboratory Medicine, University of California, San Francisco 94143.
Find articles by Coughlin, S. in: JCI | PubMed | Google Scholar
Published April 1, 1992 - More info
Platelet activation by thrombin is critical for hemostasis and thrombosis. Structure-function studies with a recently cloned platelet thrombin receptor suggest that a hirudin-like domain in the receptor's extracellular amino terminal extension is a thrombin-binding determinant important for receptor activation. We now report that a peptide antiserum to this domain is a potent and specific antagonist of thrombin-induced platelet activation. This study demonstrates that the cloned platelet thrombin receptor is necessary for platelet activation by thrombin, and provides a strategy for developing blocking monoclonal antibodies of potential therapeutic value.
Images.
Click on an image below to see the page. View PDF of the complete article